This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
ProFACT Proteomics has developed a proteomics separations and enrichment platform that streamlines
proteomic workflows while also preserving biological integrity. Using these new tools, proteomic and
molecular profiles can be derived from biofluids and naturally-sourced disease tissue or cellular models ? a
clear distinction to other functional platforms reliant on recombinant sources. New therapeutic compounds
can be characterized to help refine lead candidate selection, discover novel biomarkers and provide additional
mechanistic insight into suitable disease indications.Functional characterization and derivative molecular
profiles can then help correlate proteins thus identified to drug candidates? tissue-specific expression of enzymes,
with the potential to gauge promiscuity and identify biomarkers. Furthermore, to enrich low abundance proteins,
LC-MS strategies adopting on-bead digestion to improve peptide recovery and simplify proteomic workflows
will be described. We envision that new functional annotation methods will complement conventional sequence
annotation while addressing the problems of drug promiscuity and the subtleties of protein attributes when
the same or similar underlying sequence can have multiple conformations and functions, and when different
sequences sometime perform the same or similar function. Thus, new enrichment products make possible a
way to efficiently sift through these biological complexities, localizing subproteomes of prospective protein
biomarkers that can be correlated to structural and sequence relationships. Such an integrated approach has the
potential for new and useful service to biomarker discovery and personalized medicine.
Kuruc is a serial entrepreneur, starting as a co-founder of Affinity Technology Inc., where he was President from 1990 until 1996 .
After it was acquired by LigoTech, Inc., he held an executive business development role until becoming a co-founder of ProFACT
Proteomics in 2004. From 1987 to 1990 he held various marketing and sales positions with Amicon Division of W. R. Grace & Co.
(now Millipore), and prior to that, product and sales positions with industrial separations equipment suppliers.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals